Teledyne and Varex Filed Premerger Notifications
The companies submitted mandatory filings to trigger the regulatory review process for their proposed merger.
Updated on Sept. 21, 2026 in Healthcare
Live Poll
Do you believe major corporate mergers typically benefit the average consumer?
Teledyne Technologies and Varex Imaging have submitted Hart-Scott-Rodino premerger notifications to the Federal Trade Commission and the Department of Justice. This action officially initiates a mandatory 30-day regulatory waiting period.
Why it matters
The filing marks a formal step in the antitrust review process necessary for the companies to move forward with their proposed merger. These notifications are legally required to ensure that the combination of the two firms undergoes appropriate federal oversight.
The companies triggered a 30-day regulatory waiting period as part of the Hart-Scott-Rodino filing process. This review window is scheduled to expire on October 16, 2026.
The players
Teledyne Technologies
Teledyne Technologies is a conglomerate that provides enabling technologies for industrial growth markets and aerospace and defense applications.
Varex Imaging
Varex Imaging is a designer and manufacturer of X-ray imaging components, including tubes, digital detectors, and software solutions.
The details
The merger process requires regulatory clearance across multiple international markets, including Austria, China, Germany, Japan, Saudi Arabia, and Ukraine. Additionally, the deal is subject to a review under the United Kingdom's National Security and Investment Act of 2021.
Timeline
September 16, 2026: Companies filed Hart-Scott-Rodino premerger notifications.
October 16, 2026: Regulatory waiting period expiration.
Market Landscape
This transaction follows the standard procedure mandated by the Hart-Scott-Rodino Antitrust Improvements Act. The filings represent a critical phase in the consolidation process for firms operating in highly technical industrial and imaging sectors.
The filing process indicates the companies are working toward a merger that may eventually alter product availability or support for customers in the imaging market. Customers should monitor for updates on how the combined entity might restructure service offerings.
The takeaway
Large-scale corporate mergers are subject to lengthy global regulatory reviews to ensure market competitiveness. Stakeholders in affected industries should anticipate a month-long wait for the initial U.S. regulatory milestone.
What happens next
The mandatory 30-day regulatory waiting period is scheduled to expire on October 16, 2026.
Further reading
Learn more about industry trends in the Healthcare sector.
Source note: This article includes information reported by Mlex.
Live Poll
Do you believe major corporate mergers typically benefit the average consumer?
